Zepbound Injection(Tirzepatide)

Zepbound contains tirzepatide, a GIP and GLP-1 receptor agonist used in combination with a reduced-calorie diet and increased physical activity to support weight reduction and long-term weight maintenance in eligible adults with obesity or overweight with at least one weight-related health condition. It is administered by subcutaneous injection once weekly as prescribed by a healthcare professional.

Key Features & Specifications

Active ingredient: Tirzepatide
Medicine class: GIP and GLP-1 receptor agonist
Administration: Subcutaneous injection
Frequency: Once weekly
Available strengths: 2.5 mg–15 mg
Primary use: Weight reduction and long-term weight maintenance
Manufacturer: Eli Lilly
Prescription: Yes

Price range: €150,00 through €400,00

Dosage	Clear

Compare

Add to wishlist

SAVE 15%

more 2 products

SAVE 50%

6 for the price of 3

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.